Replies to post #47410 on Amarin Corp Plc (AMRN)

[HDGabor]

2 year extension (99,99%) or 5 years from decision (00,01%)

Depomed / Gralise: "Court will order the FDA to recognize orphandrug
marketing exclusivity for Gralise for a period of seven years from the date the FDA approved Gralise for marketing."